Clinical Trial: FemiClock: Non-invasive Tools Development (Salivary and Hair Progesterone) for Ovulation Detection in Heathy Women With Regular Menstrual Cycles Without Contraception.

U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07687823) titled 'FemiClock: Non-invasive Tools Development (Salivary and Hair Progesterone) for Ovulation Detection in Heathy Women With Regular Menstrual Cycles Without Contraception.' on June 30.

Brief Summary: Currently, the gold standard to confirm ovulation is measuring LH and/or progesterone in blood.

However, because confirmation requires a blood sample, this approach is not suitable for epidemiological studies evaluating the impact of various factors on ovulation.

Additionally, in cases of irregular menstrual cycles, there is additional difficulty in determining when the blood sample should be taken.

Our objective is the development of non...